Senate HELP Committee Advances Bipartisan Legislation to Renew Nation’s Commitment to Addressing the Alzheimer’s Crisis

FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease

Recognizing AIM’s June Advocate of the Month: Mike Razzi